1. Home
  2. Live Updates
  3. Medication guide

Live Breaking News & Updates on Medication guide

Stay informed with the latest breaking news from Medication guide on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Medication guide and stay connected to the pulse of your community

New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study

New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

North-chicago , Illinois , United-states , Chicago , Ohio , Fiji , Viti , Roopal-thakkar , J-clin-dermatol , Exchange-commission , Program-to-assess-adverse-events , Twitter

Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands

Consumers Can Apply for a Chance to Be Featured in Upcoming Campaigns for BOTOX® Cosmetic, the JUVÉDERM® Collection of Fillers, and Allē, the Allergan Aesthetics Loyalty Rewards ProgramIRVINE,...

Jasson-gilmore , Asmeret-berhe-lumax , Tomi-talabi , Lou-gehrig , Allergan-aesthetics-loyalty-rewards-program , Instagram , Beauty-club , Youtube , Product-support-department , Twitter , Allergan

Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis

Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Fiji , Ohio , United-states , Viti , Kori-wallace , Program-to-assess-adverse-events , Twitter , Instagram , Facebook , Exchange-commission , Abbvie-inc , Linkedin

UPSHER-SMITH PREVIEWS EXPANSION OF ITS RARE DISEASE PORTFOLIO AT 2024 AAN ANNUAL MEETING

/PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be participating in the 2024 American Academy of Neurology (AAN)...

Denver , Colorado , United-states , Maple-grove , Taiwan , American , Prnewswire-upsher-smith-laboratories , American-academy-of-neurology-annual-meeting , Upsher-smith-laboratories , Program-at-booth , American-academy-of-neurology

Marius Pharmaceuticals Announces Final Published Phase 3 Data from MRS-TU-2019EXT Studying the Safety and Efficacy of FDA-Approved KYZATREX® (testosterone undecanoate) CII Capsules

/PRNewswire/ -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, today announced...

United-states , American , Amyb-odonnell , Jamess-bernstein , Andreb-araujo , Thomasg-travison , Shalin-shah , Johnb-mckinlay , Varant-kupelian , J-clin-endocrinol , Marius-pharmaceuticals , Data-published

Marius Pharmaceuticals Announces Final Published Phase 3 Data from MRS-TU-2019EXT Studying the Safety and Efficacy of FDA-Approved KYZATREX® (testosterone undecanoate) CII Capsules

Marius Pharmaceuticals Announces Final Published Phase 3 Data from MRS-TU-2019EXT Studying the Safety and Efficacy of FDA-Approved KYZATREX® (testosterone undecanoate) CII Capsules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Varant-kupelian , J-clin-endocrinol , Jamess-bernstein , Johnb-mckinlay , Thomasg-travison , Shalin-shah , Amyb-odonnell , Andreb-araujo , Marius-pharmaceuticals , Data-published

Addressing Misinformation

Addressing Misinformation
kcci.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kcci.com Daily Mail and Mail on Sunday newspapers.

Novo-nordisk , Medication-guide ,

IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial

First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial

...

United-states , China , United-kingdom , Amsterdam , Noord-holland , Netherlands , Japan , Cambridge , Cambridgeshire , America , American , Suresh-senan

World Vaccine Congress Washington: Antibody persistence of a single-dose live-attenuated chikungunya virus vaccine in adults -April 04, 2024 at 01:54 am EDT

Antibody persistence of a single-doselive-attenuated chikungunya virus vaccine in adults.


World Vaccine Congress, Washington 03-Apr-2024


...

Washington , District-of-columbia , United-states , Japan , Canada , South-africa , Paraguay , Antarctica , Tanzania , Brazil , Philippines , Japanese

VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH

VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shiga , Japan , China , Cambridge , Cambridgeshire , United-kingdom , Boston , Massachusetts , United-states , Germany , Glasgow , Glasgow-city